Group 1: Company Overview - Morgan Stanley initiates coverage on InnoPhase (02577) with an Equal Weight rating and a target price of HKD 95, noting that the stock price has nearly doubled since the announcement of its partnership with NVIDIA in July 2025, while the Hang Seng Index rose by 8% during the same period [1] - InnoPhase is expected to benefit from long-term growth drivers such as AI data centers, humanoid robots, and electric vehicles, although the current stock price reflects much of the growth potential already [1][3] Group 2: Market Potential - The GaN (Gallium Nitride) market is projected to reach a total potential market size of USD 346 million in 2024, within the broader semiconductor industry valued at USD 631 billion, with a forecasted compound annual growth rate (CAGR) of 49% from 2024 to 2029 [2] - Key growth factors for the GaN market include the adoption of 800V high-voltage DC power conversion in data centers, increased use of servomotors in humanoid robots, applications in electric vehicles (such as onboard chargers and LiDAR), and the demand for fast charging in consumer electronics [2] Group 3: Competitive Landscape - InnoPhase's vertical integration manufacturing model provides advantages in technology synchronization, stable production capacity, and cost efficiency, leading to an expected growth rate that surpasses the overall market [3] - Strategic partnerships with leading clients, including NVIDIA for AI data centers, Hesai Technology and Supcon for electric vehicles, and Zhiyuan Robotics for humanoid robots, highlight InnoPhase's technological leadership and strong growth potential [3] Group 4: Industry Challenges - The global GaN production capacity is projected to increase from 100,000 wafers per month in 2024 to 345,000 wafers per month by 2029, indicating potential oversupply in the market [4] - Despite an anticipated increase in capacity utilization, the overall utilization rate is expected to remain below 60% over the next five years, which may pressure pricing and profitability in the GaN market [4] - InnoPhase's gross margin is expected to improve moderately by 2026/27, reflecting the ongoing competitive pressures and potential for overcapacity [4]
大摩：首予英诺赛科(02577)目标价95港元 受益于多项长期增长驱动因素